http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-52557-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcbc1de8801460caf80ad76627ae20b0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0093 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-91 |
| filingDate | 1982-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1987-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-52557-B1 |
| titleOfInvention | Nitroimidazole derivatives |
| abstract | Platinum(II)-containing complexes of nitroimidazoles of the formula: {X!2PtII(z1) 2 I wherein X represents a 2-, 4- or 5-(mono)nitroimidazole molecule which is unsubstituted or carries at least one substituent, and which can coordinate to platinum through the 3-position of the heterocyclic ring, and z1 represents a pharmaceutically-acceptable ligand known not to be capable of coordinating to platinum more strongly than the 3-position nitrogen atom of the imidazole ring of a 2-, 4- or 5-(mono)nitroimidazole molecule represented by the symbol X are of use in the therapy of cancer and in combatting anaerobic bacterial infections. |
| priorityDate | 1981-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.